A practical approach to diagnosing adult onset leukodystrophies

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 7, 2014, Pages 770-781

  Ahmed, R M ^a   Murphy, E ^a   Davagnanam, I ^a   Parton, M ^a   Schott, J M ^a   Mummery, C J ^a   Rohrer, J D ^a   Lachmann, R H ^a   Houlden, H ^a   Fox, N C ^a   Chataway, J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHENODEOXYCHOLIC ACID; MYELIN;

ADRENOLEUKODYSTROPHY; ADULT; ADULT ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY; ADULT POLYGLUCOSAN BODY DISEASE; AGE DISTRIBUTION; ALEXANDER DISEASE; BRAIN BIOPSY; CADASIL; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ETHNICITY; FAMILY HISTORY; GENETIC COUNSELING; GENETIC DISORDER; GLOBOID CELL LEUKODYSTROPHY; HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROID; HUMAN; LEUKODYSTROPHY; METACHROMATIC LEUKODYSTROPHY; MULTIPLE SCLEROSIS; NEUROAXONAL DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOGENESIS; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; REVIEW; VANISHING WHITE MATTER DISEASE; WHITE MATTER LESION;

ADRENOLEUKODYSTROPHY; CADASIL; CLINICAL NEUROLOGY; METABOLIC DISEASE; NEUROGENETICS;

ADRENOLEUKODYSTROPHY; ADULT; AGE OF ONSET; BIOPSY; BRAIN; CADASIL; DIAGNOSIS, DIFFERENTIAL; HEREDITARY CENTRAL NERVOUS SYSTEM DEMYELINATING DISEASES; HUMANS; LEUKODYSTROPHY, GLOBOID CELL; LEUKODYSTROPHY, METACHROMATIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROIMAGING; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 84902275072     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-305888     Document Type: Review

References (76)

1. Renaud DL. Clinical approach to leukoencephalopathies. Semin Neurol 2012;32:29-33.
2. Costello DJ, Eichler AF, Eichler FS. Leukodystrophies: classification, diagnosis and treatment. Neurologist 2009;15:319-28.
3. Maria BL, Deidrick KM, Moser H, et al. Leukodystrophies: pathogenesis, diagnosis, strategies, therapies, and future research directions. J Child Neurol 2003;18:578-90.
4. Moser HW, Mahmood A, Raymond GVC. X linked adrenoleukodystrophy. Nat Clin Pract Neurol 2007;3:140-51.
5. Van Geel BM, Beman L, Loes DJ, et al. Evolution of phenotypes in adult male patients with x-linked adrenoleukodystrophy. Ann Neurol 2001;49:186-94. (Pubitemid 32157994)
6. Narayan SK, Gorman G, Kalaria RN, et al. The minimum prevalence of CADASIL in northeast England. Neurology 2012;78:1025-7.
7. Chabriat H, Joutel A, Dichgans M, et al. CADASIL. Lancet Neurol 2009;8:643-53.
8. Sedel F, Tourbah A, Fontaine B, et al. Leukoencephalopathies associated with in born errors of metabolism in adults. J inherit metab dis 2008;31:295-307.
9. Wenger DA, Suzuki K, Suzuki Y, et al. Galaclosylceramide lipidosis globoid cell leukodystrophy (Krabbe disease). In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The Metabolic and molecular bases of inherited disease. 8th edn. New York: McGraw Hill 2001:3669-94.
10. Heinisch U, Zlotogora J, Kafert S, et al. Multiple mutations are responsible for the high frequency of metochromatic leukodystrophy in a small geographic area. Am J Hum genet 1995;56:51-7.
11. Lorincz MT, Rainer S, Thomas D, et al. Cerebrotendinous xanthomatosis, possible higher prevalence than previously recognized. Arch Neurol 2005;62:1459-63. (Pubitemid 41352065)
12. Garone C, Tadesse S, Hirano M. Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain 2011;134:3326-32.
13. Schaefer AM, McFarland R, Blakely EL, et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008;63:35-9. (Pubitemid 351240549)
14. Wong LJC. Mitochondrial syndromes with leukoencephalopathies. Semin Neurol 2012;32:55-61.
15. Wong JC, Chow TW, Hazrati LN. Adult onset leukoencephalopathy with axonal spheroids and pigmented glia can present as frontotemporal dementia syndrome. Dement geriatr cogn disord 2011;32:150-8.
16. Savage G, Ray F, Halmagyi M, et al. Stable neuropsychological deficits in adult polyglucosan body disease. J Clin Neurosci 2007;14:473-7. (Pubitemid 46453183)
17. Pareyson D, Fancellu R, Mariotti C, et al. Adult onset Alexander disease: a series of 11 unrelated cases with review of the literature. Brain 2008;131:2321-31.
18. Tillema JM, Renaud DL. Leukoencephalopathies in adulthood. Semin Neurol 2012;32:85-94.
19. Melberg A, Hallberg C, Kalimo H, et al. MR characteristics and neuropathology in adult onset autosomal dominant leukodystrophy with autonomic symptoms. AJNR Am J Neuroradiol 2006;27:904-11. (Pubitemid 44897747)
20. Labauge P, Horzinski L, Ayrignac X, et al. Natural history of adult onset eIF2B related disoders: a multi centric survey of 16 cases. Brain 2009;132:2162-9.
21. Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. J Stroke Cerebrovasc Dis 2011;20:85-93.
22. MaGueen GM, Rosebush PI, Mazurek MF. Neuropsychiatric aspects of the adult variant of Tay Sachs disease. J Neuropsychiatry Clin Neurosci 1998;10:10-19.
23. Blattner R, Van Moers A, Leegwater PAJ, et al. Clinical and genetic heterogeneity in megalencephalic leukoencephalopathy with subcortical cysts. Neuropediatrics 2003;34:215-18. (Pubitemid 37152793)
24. Birnbaum T, Blam HJ, Prokisch H, et al. Methylenetetrahydrofolate reductase deficiency (homocystiuria type II) as a rare cause of rapidly progressive tetraspasticity and psychosis in a previously healthy adult. J Neurol 2008;255:1845-6.
25. Gutschalk A, Harting I, Cantz M, et al. Adult alpha mannosidosis. Clinical progression in the absence of demyelination. Neurology 2004;63:1744-6. (Pubitemid 39507608)
26. Reis S, Sheffer RN, Merin S, et al. Mucolipidosis type IV; a mild form with late onset. Am J med genet 1993;47:392-4. (Pubitemid 23263643)
27. Varho T, Jaaskelainen S, Tolonen U, et al. Central and peripheral nervous system dysfunction in the clinical variation of Salla disease. Neurology 2000;55:99-104.
28. Kulkens S, Harting I, Sauer S, et al. Late onset neurologic disease in glutaryl- CoA dehydrogenase deficiency. Neurology 2005;64:2142-4. (Pubitemid 40881012)
29. Owens WE, Okun MS. Dystonia, tremor, and parkinsonism in a 54-year-old man with 2- hydroxyglutaric aciduria. J Neurol Neurosurg Psychiatry 2004;75:1362-3. (Pubitemid 39141355)
30. Eriguchi M, Mizuta H, Kurohara K, et al. 3-methylglutaconic aciduria type 1 causes leukoencephalopathy of adult onset. Neurology 2006;67:1895-6. (Pubitemid 44900784)
31. Bischof F, Nagele T, Wanders RJ, et al. 3 Hydroxy 3- methylglutaryl CoA lyse deficiency in an adult with leukoencephalopathy. Ann Neurol 2004;56:727-30. (Pubitemid 39540756)
32. Sasaki A, Miyanaga K, Ototsuji M, et al. Two autopsy cases with Pelizaeus-Merzbacher disease phenotype of adult onset, without mutation of proteolipid protein gene. Acta Neuropathol 2000;99:7-13. (Pubitemid 30093432)
33. Warshawsky I, Rodick RA, Staugaitis SM, et al. Primary progressive multiple sclerosis as a phenotype of PLP1 gene mutation. Ann Neurol 2005;58:470-3. (Pubitemid 41266636)
34. Nezu A, Kimura S, Uehara S, et al. Pelizaeus- Merzbacher like disease: female case report. Rain dev 1996;18:114-18.
35. Tzoulis C, Tran GT, Gjerde IO, et al. Leukoencephalopathy with brainstem and spinal ord involvement caused by a novel mutation in the DARS2 gene. J Neurol 2012;259:292-6.
36. Kaneko M, Sano K, Nakayama J, et al. Nasu- Hokola disease: the first case reported by Nasu and review. Neuropathology 2010;30:463-70.
37. Natale V. A comprehensive description of the severity groups in cockayne syndrome. Am J Med Genet 2011;155:1081-95.
38. Lourenco P, Shirani A, Saeedi J, et al. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression. Mult Scler 2013;19:577-84.
39. Schiffmann R, van der Knapp MS. An MRI based approach to the diagnosis of white matter disorders. Neurology 2009;72:750-9.
40. Kohler W. Diagnostic algorithm for the differentiation of leukodystrophies in early MS. J Neurol 2008;255:123-6.
41. Charil A, Yousry TA, Rovaris M, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neuol 2006;5:841-52. (Pubitemid 44715819)
42. Runia TF, Jafar N, Hintzen RQ. Application of the 2010 revised criteria fort he diagnosis of multiple sclerosis to patients with clinically isolated syndrome. Eur J Neurol 2013. epub ahead of print.
43. Hardy TA, Chataway J. Tumefactive demyelination: an approach to diagnosis and management. J Neurol Neurosurg Psychiatry 2013;84:1047-53.
44. Cabrejo L, Guyant-Marechal L, Laquerriere A, et al. Phenotype associated with APP duplication in five families. Brain 2006;129:2966-76. (Pubitemid 44684517)
45. Rademakers R, Baker M, Nicholson AM, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 2012;44:200-5.
46. Beck J, Pittman A, Adamson G, et al. Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiol Aging 2014;35;261-5.
47. Gilkes CE, Love S, Hardie RJ, et al. Brain biopsy in benign neurological disease. J Neurol 2012;259:995-1000.
48. Rice CM, Gilkes CE, Teare E, et al. Brain biopsy in cryptogenic neurological disease. British J Neurosurg 2011;25:614-20.
49. Schott JM, Reineiger L, Thom M, et al. Brain biopsy in dementia: clinical indications and diagnostic approach. Acta Neuropathol 2010;120:327-41.
50. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997;120:1485-508. (Pubitemid 27344713)
51. Patay Z. Diffusion weighted MR imaging in leukodystrophies. Eur Radiol 2005;15:2284-303.
52. Fatema A, Barker PB, Ulug AM, et al. MRI and proton MRSI in women heterozygote for adrenoleukodystrophy. Neurology 2003;60:1301-7. (Pubitemid 36460986)
53. Wegner DA, Rafi MA, Luzi P. Molecular genetics of Krabbe disease (globoid cells=leukodystrophy): diagnostic and clinical implications. Hum Mutat 1997;10:268-79. (Pubitemid 27430501)
54. Barone R, Bruhl K, Stoeter P, et al. Clinical and neuroradiological findings in classic infantile and late onset globoid- cell leukodystrophy (Krabbe disease). Am J Med Genet 1996;63:209-17.
55. Wenger DA, Rafi MA, Luzi P, et al. Krabbe disease: genetic aspects and progress towards therapy. Mol Genet Metab 2000;70:1-9. (Pubitemid 30396199)
56. Husain AM, Altuwaijri M, Aldosari M. Krabbe disease: neurophysiologic studies and MRI correlations. Neurology 2004;63:617-20. (Pubitemid 39100814)
57. Van der Knapp MS, Valk J. eds Magnetic resonance of Myelination and Myelin Disorders. 3rd ed. Berlin: Springer, 2005.
58. Farina L, Bizzi A, Finocchiaro G, et al. MR imaging and proton MR spectroscopy in adult krabbe disease. AJNR Am J Neuroradiol 2000;21:1478-82.
59. Federico A, Dotti MT. Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis and therapy. J Child Neurol 2003;18:633-8. (Pubitemid 37258469)
60. Federico A, Dotti MT, Lore Nutti R. Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism. J Neurol Sci 1993;115:67-70. (Pubitemid 23090187)
61. Verrips A, Hoefsloot LH, Steenbergen GC, et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 2000;123:908-19. (Pubitemid 30224187)
62. Hageman AT, Gabreels FJ, De Jong JG, et al. Clinical symptoms of adult metachromatic leukodystrophy and arylsulfatase A pseudodeficiency. Arch Neurol 1995;52:408-13.
63. Mahmood A, Berry J, Wenger DA, et al. Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature. J Child Neurol 2010;25:572-80.
64. McFarland R, Taylor RW, Turnbull DM. A neurological perspective on mitochondrial disease. Lancet Neurol 2010;9:829-40.
65. Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, et al. White matter involvement in mitochondrial diseases. Mol Genet Metab 2005;84:127-36. (Pubitemid 40164572)
66. Sundal S, Lash J, Aasly J, et al. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J Neurol Sci 2012;314:130-7.
67. Sundal C, Van Gerpen JA, Nicholson A, et al. MRI characteristics and scoring in HDLS due to CSF1R gene mutation. Neurology 2012;79:566-74.
68. Ziemssen F, Sindern E, Schroder JM, et al. Novel missense mutations in the glycogen branching enzyme gene in adult polyglucosan body disease. Ann Neurol 2000;47:536-40. (Pubitemid 30194615)
69. Mochel F, Schiffmann R, Steenweg ME. Adult Polyglucosan body disease. Natural history and key magnetic resonance imaging findings. Ann Neurol 2012;72:433-41.
70. Farina L, Pareyson D, Minati L, et al. Can MR imaging diagnose adult onset alexander disease. AJNR Am J Neuroradiol 2008;29:1190-6. (Pubitemid 351954892)
71. Van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001;22:541-52. (Pubitemid 32221425)
72. Marble M, Voeller KS, May MM, et al. Pelizaeus-Merzbacher syndrome: neurocognitive function in a family with carrier manifestations. Am J Med Genet 2007;143A:1442-7. (Pubitemid 47051022)
73. Nezu A, Kimura S, Takeshita S, et al. An MRI and MRS Study of Pelizaeus-Merzbacher Disease. Paediatr Neurol 1998;18:334-7. (Pubitemid 28191528)
74. Online Mendelian Inheritance in Man, OMIM®. Baltimore, MD: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, 2013. http://omim.org/
75. Donaghy M, King RH, Mckeran RO, et al. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid. J Neurol 1990;237:216-19. (Pubitemid 20209312)
76. Yahalom G, Tsabari R, Molshatzki N, et al. Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis. Clin Neuropharmacol 2013;36:78-83.